Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Mego M.
  • Israelyan E.
  • Hamilton R.J.
  • Heidenreich A.
  • Basso U.
  • Giannatempo P.
  • Buchler T.
  • Dieckmann K.-P.
  • Huddart R.
  • Vincenzi B.
  • Park K.
  • Tryakin A.
  • Amiri A.
  • Malcharkova P.
  • Claps M.
  • Miletic M.
  • Chaloupkova L.
  • Angerer M.
  • Spiess P.E.
  • De Giorgi U.

Grupos

Abstract

Background: Germ cell tumors (GCTs) are highly curable, yet a subset of patients with metastatic disease experience early death (ED) soon after starting first-line chemotherapy. These patients are underrepresented in trials, and risk factors remain unclear. Methods: We performed a retrospective multicenter cohort study including adults ( = 18 years) with metastatic GCT who died within 3 months of completing their last cycle of first-line chemotherapy. Primary outcomes were cause and timing of death; secondary endpoints included clinical predictors of acute respiratory failure (ARF) and very early death ( = 30 days). Results: Among 102 patients (1.7% of treated cases), 69.6% had non-seminoma, 83.3% testicular primaries, and 67.6% poor-risk disease. Median time to death was 28 days (range, 2–179). Leading causes were ARF (34.1%), disease progression (16.7%), septic shock (15.7%), hemorrhage (12.7%), and cardiovascular events (4.0%). ARF correlated with > 50% lung involvement, dyspnoea, and haemoptysis, but not choriocarcinoma histology or bleomycin use. Mostly, ED (51%) was associated with liver metastases, massive lung involvement, ß-hCG > 50,000 mIU/mL, ECOG 2–3, elevated neutrophil/lymphocyte ratio, and need for intensive care (all P < 0.05). Conclusions: Early death in metastatic GCT, though rare, remains a critical clinical issue. Early identification, adapted induction regimens, and optimized supportive care may help prevent avoidable mortality. © The Author(s) 2026.

Datos de la publicación

ISSN/ISSNe:
0007-0920, 1532-1827

BRITISH JOURNAL OF CANCER  SPRINGERNATURE

Tipo:
Article
Páginas:
-
PubMed:
42231028
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
2,272 SCImago ℠
Cuartil:
Q1 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Cita

Compartir